Standard Operating Procedure for Testing Content Uniformity of Cream Products in Process
| Department | Creams |
|---|---|
| SOP No. | SOP/CRM/169/2025 |
| Supersedes | SOP/CRM/169/2022 |
| Page No. | Page 1 of 5 |
| Issue Date | 21/01/2026 |
| Effective Date | 26/01/2026 |
| Review Date | 21/01/2027 |
1. Purpose
The purpose of this SOP is to define the procedure for testing content uniformity of cream products during the manufacturing process. Ensuring that the active ingredients and other components are evenly distributed throughout the batch is essential for product consistency, efficacy, and safety.
2. Scope
This SOP applies to the process of testing content uniformity during cream manufacturing. It covers sampling procedures, the testing methods for active ingredients, and the steps to ensure that the cream batch meets uniformity standards before progressing to the filling stage.
3. Responsibilities
- Production Team: Responsible for providing cream samples at specified intervals during the production process to ensure uniform distribution of active ingredients.
- Quality Control (QC) Team: Responsible for performing content uniformity tests, analyzing the results, and ensuring that the cream meets the required uniformity standards.
- Laboratory Supervisor: Responsible for reviewing content uniformity test results and approving the batch for further processing if the test results meet specifications.
- Maintenance
4. Accountability
The Production Manager is accountable for ensuring that content uniformity is tested as per this SOP. The QC Manager is responsible for overseeing the testing and ensuring that any deviations are addressed. The Laboratory Supervisor is accountable for reviewing the results and ensuring compliance with product specifications before the batch proceeds to filling.
5. Procedure
5.1 Pre-Testing Setup
- Ensure that the production process has reached the appropriate stage (typically after homogenization and before filling) to test the content uniformity of the cream batch.
- Verify that all equipment and instruments used for sampling and testing (e.g., sample containers, balances, HPLC equipment) are clean, calibrated, and functioning properly.
- Ensure that the sampling procedure and test methods for content uniformity are defined in the Batch Manufacturing Record (BMR) or product specifications.
5.2 Sampling Procedure
- Take representative samples of the cream at multiple points in the batch during the production process to ensure uniform distribution of the active ingredients. Samples should be taken from different locations (e.g., top, middle, bottom) within the batch container.
- Ensure that the sample volume is sufficient for the required tests (e.g., chemical analysis, active ingredient content, etc.).
- Label each sample with the batch number, sampling date, time, and other relevant details to maintain traceability.
- Transfer the samples to the QC laboratory immediately for testing, ensuring they are not exposed to temperature or environmental fluctuations.
5.3 Content Uniformity Testing
- Testing Method: Perform content uniformity tests using the appropriate method, such as High-Performance Liquid Chromatography (HPLC), spectrophotometry, or another validated method for measuring the active ingredient content in the cream.
- Uniformity Criteria: Ensure that the active ingredient content in all samples is within the acceptable range specified in the product specifications (usually ±10% of the label claim for cream products).
- Analysis: Analyze the test results to confirm that the cream batch is uniform in terms of active ingredient distribution. If any sample falls outside the acceptable range, a deviation procedure must be initiated.
- Record the test results in the Content Uniformity Log (Annexure-1), including details such as sample ID, test method, test results, and remarks.
5.4 Handling Deviations
- If any sample’s active ingredient content is outside the acceptable range, immediately document the deviation in the Deviation Report (Annexure-2).
- Investigate the cause of the deviation, which could include improper mixing, incorrect ingredient proportions, or equipment malfunction.
- Take corrective actions, which may include re-blending the batch, adjusting ingredient ratios, or reworking the batch if necessary.
- If the deviation is critical, halt the production process and evaluate whether the batch should be rejected or if further adjustments are needed before proceeding.
- Ensure that all deviations are thoroughly documented and reviewed by the QC and Laboratory Supervisors.
5.5 Post-Testing Activities
- Once the content uniformity tests are completed and the results are within the specified limits, approve the batch for the next stage (e.g., filling or packaging).
- If the batch passes the test, proceed with transferring the cream to the filling line for packaging.
- If the batch fails the test, reject the batch or initiate rework according to the Batch Rework SOP (SOP/CRM/004/2025).
5.6 Documentation and Record-Keeping
- Record all content uniformity testing data in the Content Uniformity Log (Annexure-1), including sample details, test results, and operator information.
- Document any deviations and corrective actions in the Deviation Report (Annexure-2), ensuring that all necessary details are captured.
- Maintain all records for a minimum of two years or as required by regulatory guidelines to ensure traceability and compliance during audits.
- Ensure that all records are reviewed and signed by the operator performing the test, the QC team, and the Laboratory Supervisor for verification and approval.
6. Abbreviations
- GMP: Good Manufacturing Practices
- QC: Quality Control
- QA: Quality Assurance
- BMR: Batch Manufacturing Record
- PPE: Personal Protective Equipment
- HPLC: High-Performance Liquid Chromatography
7. Documents
- Annexure-1: Content Uniformity Log
- Annexure-2: Deviation Report
8. References
- Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
- International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
- FDA Guidance for Industry: Content Uniformity Testing
9. SOP Version
Version: 2.0
10. Approval Section
| Prepared By | Checked By | Approved By | |
|---|---|---|---|
| Signature | |||
| Date | |||
| Name | |||
| Designation | |||
| Department |
11. Annexures
Annexure-1: Content Uniformity Log
| Batch Number | Sample Location | Test Method | Test Result | Operator | Remarks |
|---|---|---|---|---|---|
| 12345 | Top | HPLC | Pass (±5%) | John Doe | Uniform distribution |
| 12345 | Middle | HPLC | Pass (±5%) | Jane Smith | Uniform distribution |
| 12345 | Bottom | HPLC | Pass (±5%) | Michael Lee | Uniform distribution |
Annexure-2: Deviation Report
| Batch Number | Deviation Description | Corrective Action | Resolved By |
|---|---|---|---|
| 12345 | Content outside acceptable range | Reworked formulation | Jane Smith |
Revision History:
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 01/03/2024 | 1.0 | Initial Version | New SOP Creation | QA Head |
| 01/03/2025 | 2.0 | Format Revision and Updates | Standardization of Document | QA Head |